Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 34Unknown 18Recruiting 13Terminated 7Active not recruiting 5Withdrawn 3Not yet recruiting 2No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Classical hematology 1

Conditions

Breast Neoplasms 333Neoplasms 221Prostatic Neoplasms 197Carcinoma, Non-Small-Cell Lung 156Lung Neoplasms 135Pancreatic Neoplasms 118Colorectal Neoplasms 103Neoplasm Metastasis 100Carcinoma, Hepatocellular 96Leukemia, Myeloid, Acute 94Multiple Myeloma 91Brain Neoplasms 89Lymphoma 86Head and Neck Neoplasms 76Melanoma 73Ovarian Neoplasms 72Leukemia 71Leukemia, Lymphocytic, Chronic, B-Cell 69Glioblastoma 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Colonic Neoplasms 61Recurrence 59Lymphoma, Non-Hodgkin 54Rectal Neoplasms 50Hematologic Neoplasms 50Lymphoma, Follicular 49Glioma 49Squamous Cell Carcinoma of Head and Neck 47Lymphoma, Large B-Cell, Diffuse 47Carcinoma, Renal Cell 47

Interventions

bavituximab 1avatrombopag 1Sorafenib 1Radiotherapy 1Radiosurgery 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Liver Diseases × Clear all
NCT05817994 2024-11-19

REGAL

Sheikh Shakhbout Medical City

Withdrawn
Gastrointestinal

Hepatitis, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure, Acute

NCT04437953 2020-12-08

Avatrombopag for Thrombocytopenia in People With Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn
Classical hematology

Liver Diseases, Neoplasms, Thrombocytopenia

NCT02989870 2020-06-05

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡